Report of families with Steinert´s Myotonic Dystrophy surveyed in Primary Health Care
Keywords:
MYOTONIC DYSTROPHY, PRIMARY HEALTH CARE.Abstract
Introduction: the dystrophy miotónica of Steinert. It is an illness I inherit family with pattern of transmission dominant autosómico.
Objective: to describe families with Steinert´s Myotonic Dystrophy, surveyed in Primary Health Care.
Report of families: it is about a sample of 126 members belonging to two families, in which several of their members had been diagnosed with the entity; both families are from Pinar del Río province, Cuba. A survey was conducted during 2019, and between January and March 2020, each member of both families had their genealogies completed and their clinical characteristics evaluated; working with some variables related to the clinical types of this entity according to the generations.
Results: two families were presented through the genealogical tree, with 40 and 86 members from the municipalities of Minas de Matahambre and Pinar del Río municipalities respectively. In the first municipality, nine persons (9) were registered with the mild and classic type of the disease, of these more than 50 % did not know their condition, and 21 persons were apparently symptomatic. In the second municipality, 21 cases were evaluated some clinical characteristics of the disease, which with respect to the total number of cases surveyed represented 26,5 %.
Conclusions: it is essential to study families with Steinert's Myotonic Dystrophy, since there is a dissociation of clinical signs and variable expression of the disease. It is the Primary Health Care the setting which allows early diagnosis and multidisciplinary management of this disease.
Downloads
References
1. Dystrophia Myotonica, Steinert Disease, DM1 [Internet]. Baltimore: Johns Hopkins University; 2020 [actualizado 20 Feb 2020; citado 20/03/2020]. Disponible en: https://www.omim.org/entry/160900.
2. Thomas D Bird MD. Myotonic Dystrophy Type 1 [Internet]. GeneReviews ;1999 [citado 20/03/2020]: [aprox. 10p.]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK1165/.
3. Roque M, López-Argüelles J, Sánchez-Lozano A, Herrera-Alonso D, Sosa-Águila L, Rodríguez-Ramírez Y. Distrofia miotónica de Steiner en una familia. Presentación de casos. Medisur [Internet]. 2020 [citado 26/03/2020]; 18(1): [aprox. 6 p.]. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/4431
4. Informes Periódicos de Orphanet. Prevalencia de las enfermedades raras: Datos bibliográficos Inserm [Internet]. 2020 [citado 20/02/2020]; (2): [aprox. 25 p.]. Disponible en: https://www.orpha.net/orphacom/cahiers/docs/ES/Prevalencia_de_las_enfermedades_raras_por_prevalencia_decreciente_o_casos.pdf
5. Gutiérrez Gutiérrez G, Díaz Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, et al. Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert. Med Clin [Internet]. 2019 [citado 14/03/2020]; 35(3): [aprox. 15p.]. Disponible en: https://www.elsevier.es/es-revista-neurologia-295-avance-resumen-guia-clinica-el-diagnostico-seguimiento-S0213485319300192
6. Flores-López EN, Tovilla-Ruiz CK, García-Padilla E, Sandoval-Gutiérrez RB, Álvarez-Torrecilla LC. Distrofia miotónica de Steinert: caso clínico de una familia y revisión de la bibliografía. Med Int Méx [Internet]. 2014 [citado 14/03/2020]; 30:195-203. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2014/mim142j.pdf
7. Lorenzo Comas R, Valdespino A, Landrian D, Serra Ruíz M. Distrofia miotónica de Steinert. Presentación de un caso. Medisur [Internet]. 2017 [citado 14/03/2020]; 15(1): 120-125. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2017000100016
8. Johnson NE, Aldana EZ, Angeard N, Ashizawa T, Berggren KN, Marini Bettolo C, et al. Consensus based care recommendations for congenital and childhood onset myotonic dystrophy type 1. Neurol Clin Pract [Internet]. 2019 [citado 25/03/2020]; 9(5): 443–454. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814415/
9. Rosado Bartolomé A, Sierra Santos L. Distrofia miotónica de Steinert. Rev Clin Med Fam [Internet]. 2015 [citado 25/03/2020]; 8(1): 79-83. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-695X2015000100012
10. Rosado Bartolome A, Gutierrez Gutierrez G, Sierra Santos L, Sueiro Juste J. Distrofia miotónica de Steinert. Nuevos paradigmas Asistenciales. Cad Aten Primaria [Internet]. 2015 [citado 25/03/2020]; 21(4): 38-42. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=5518707
11. Barbe L, Lanni S, Lopez-Castel A, Franck S, Spits C, Keymolen K, et al. CpG methylation, a parent-of-origin effect for maternal-biased transmission of congenital myotonic dystrophy. Am. J. Hum. Genet [Internet]. 2017 [citado 25/03/2020]; 100(3): 488–505. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339342/
12. Martínez Calvo S. Logros y retos de la Atención Primaria de Salud en Cuba. Rev haban cienc méd [Internet]. 2018 [citado 25/03/2020]; 17(2):157-160. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2325
13. González Cárdenas LT, Cuesta Mejías L, Pérez Perea L, Presno Labrador MC, Fernández Díaz IE, Pérez Díaz TC, et al. El Programa del médico y enfermera de la familia: desarrollo del modelo de atención médica en Cuba. Rev Panam Salud Pública [Internet]. 2018 [citado 25/03/2020]; 42: [aprox. 5p.]. Disponible en: https://iris.paho.org/handle/10665.2/34902
14. OPS/OMS. La renovación de la Atención Primaria de Salud en las Américas. Documento de posición de la Organización Panamericana de la Salud/Organización Mundial de la Salud (OPS/OMS) [Internet] Washington, DC; 2008 [Citado 03/03/2020].Disponible en: https://cursos.campusvirtualsp.org/file.php/118/ModuloI/md3-lp-renovacion-APS-spa2007.pdf
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/